[HTML][HTML] Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer
KK Iyer, NP van Erp, DVF Tauriello… - Cancer Treatment …, 2022 - Elsevier
Patients with advanced or metastatic colorectal cancer ((m) CRC) have limited effective
treatment options resulting in high mortality rates. A better understanding of the molecular …
treatment options resulting in high mortality rates. A better understanding of the molecular …
[HTML][HTML] Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer
KK Iyer, NP van Erp, DVF Tauriello… - Cancer …, 2022 - cancertreatmentreviews.com
Patients with advanced or metastatic colorectal cancer ((m) CRC) have limited effective
treatment options resulting in high mortality rates. A better understanding of the molecular …
treatment options resulting in high mortality rates. A better understanding of the molecular …
Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer
KK Iyer, NP van Erp… - Cancer …, 2022 - researchinformation.amsterdamumc …
Patients with advanced or metastatic colorectal cancer ((m) CRC) have limited effective
treatment options resulting in high mortality rates. A better understanding of the molecular …
treatment options resulting in high mortality rates. A better understanding of the molecular …
Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer.
KK Iyer, NP van Erp, DVF Tauriello… - Cancer Treatment …, 2022 - europepmc.org
Patients with advanced or metastatic colorectal cancer ((m) CRC) have limited effective
treatment options resulting in high mortality rates. A better understanding of the molecular …
treatment options resulting in high mortality rates. A better understanding of the molecular …
Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer
KK Iyer, NP van Erp, DVF Tauriello… - Cancer treatment …, 2022 - pubmed.ncbi.nlm.nih.gov
Patients with advanced or metastatic colorectal cancer ((m) CRC) have limited effective
treatment options resulting in high mortality rates. A better understanding of the molecular …
treatment options resulting in high mortality rates. A better understanding of the molecular …
[PDF][PDF] Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer
KK Iyer, NP van Erp, DVF Tauriello, HMW Verheul… - 2022 - repository.ubn.ru.nl
Patients with advanced or metastatic colorectal cancer ((m) CRC) have limited effective
treatment options resulting in high mortality rates. A better understanding of the molecular …
treatment options resulting in high mortality rates. A better understanding of the molecular …